Recent advances in the development of multifunctional lipid-based nanoparticles for co-delivery, combination treatment strategies, and theranostics in breast and lung cancer
Cancer nanomedicines and the development of state-of-the-art multifunctional lipid-based nanoparticles (NPs) has become a fundamental resource in resolving challenging biomedical questions and physiological impediments. Since the approval of the first cancer nanomedicine by the U.S. Food and Drug Ad...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Published: |
Elsevier
2022
|
| Online Access: | http://psasir.upm.edu.my/id/eprint/103002/ |